Safety issues in vasculitis: infections and immunizations in the immunosuppressed host

Infectious diseases are a significant cause of morbidity and mortality in immunosuppressed patients, including those with connective tissue diseases. Both disease and treatment contribute to a predisposition to infection in immunocompromised patients. Significant infection and morbidity occur in 25%...

Full description

Saved in:

Bibliographic Details
Published in:	Cleveland Clinic journal of medicine Vol. 79 Suppl 3; p. S38
Main Author:	Isada, Carlos M
Format:	Journal Article
Language:	English
Published:	United States 01.11.2012
Subjects:	Aspergillosis - complications Aspergillosis - diagnosis Aspergillosis - prevention & control Connective Tissue Diseases - complications Connective Tissue Diseases - drug therapy Herpes Zoster - complications Herpes Zoster - diagnosis Herpes Zoster - prevention & control Histoplasmosis - complications Histoplasmosis - diagnosis Histoplasmosis - prevention & control Humans Immunocompromised Host Immunosuppressive Agents - adverse effects JC Virus Nocardia Infections - complications Nocardia Infections - diagnosis Nocardia Infections - prevention & control Opportunistic Infections - complications Opportunistic Infections - diagnosis Opportunistic Infections - prevention & control Pneumocystis Infections - complications Pneumocystis Infections - diagnosis Pneumocystis Infections - prevention & control Polyomavirus Infections - complications Polyomavirus Infections - diagnosis Polyomavirus Infections - prevention & control Vasculitis - complications Vasculitis - drug therapy
ISSN:	1939-2869, 1939-2869
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!